Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease
Warwick Selby(Royal Prince Alfred Hospital), David J. Hetzel(South Australia Pathology), Peter G. Gibson(Hunter Medical Research Institute), Brendan Crotty(Austin Health), William Connell(St Vincent's Hospital), R. B. Read(Hornsby Ku-ring-gai Hospital), Graham Radford‐Smith(QIMR Berghofer Medical Research Institute), M N Merrett(Frankston Hospital), Brent Mitchell(Launceston General Hospital), Hooi C. Ee(Sir Charles Gairdner Hospital), Tim Florin(Mater Health Services), Paul Pavli(Canberra Hospital)
Cited by 361
Related Papers
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
|Respirology|2006|939
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
|Gastroenterology|1988|786